Pulsenmore Partners with Ouma Health to Scale Home Ultrasound in U.S. Prenatal Care
Event summary
- Pulsenmore Ltd. (NASDAQ: PLSM) has partnered with Ouma Health to integrate its FDA-authorized home ultrasound platform into Ouma's virtual maternity care model.
- The collaboration aims to expand prenatal monitoring beyond clinics, targeting the 35% of U.S. counties classified as maternal care deserts.
- Ouma Health will incorporate Pulsenmore’s technology to enable remote prenatal ultrasound monitoring for expectant mothers nationwide.
- Pulsenmore's CEO Dr. Elazar Sonnenschein and Ouma Health's CEO Dr. Sina Haeri highlighted the partnership's role in closing critical access gaps in maternal healthcare.
The big picture
This partnership marks a strategic shift toward decentralized prenatal care, aligning with broader trends in telemedicine and remote patient monitoring. By integrating Pulsenmore's technology into Ouma Health's platform, the collaboration aims to address critical access gaps in maternal healthcare, particularly in underserved communities. The deal underscores the growing role of home-based diagnostic tools in transforming traditional clinical models.
What we're watching
- Market Expansion
- How Pulsenmore will leverage Ouma Health's established virtual care model to accelerate adoption of home ultrasound technology in the U.S.
- Regulatory Compliance
- Whether the partnership can navigate regulatory hurdles to maintain FDA authorization while scaling the technology.
- Payer Adoption
- The pace at which payer organizations will integrate home ultrasound into reimbursement models for prenatal care.
Related topics